Inozyme Pharma, Inc.
INZY
Revenue
0.00
0.000.00%
-Assets
123.18M
▼-20.18M▼-14.08%
3 Months ChangeLiabilities
65.36M
▲4.78M▲7.90%
3 Months ChangeFree Cash Flow
-24.57M
▼-6.62M▼-36.88%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-24
Form 8-K
ID: 0000950170-24-117087
2024-10-07
Form 8-K
ID: 0000950170-24-113241
2024-08-06
Form 8-K
ID: 0001193125-24-194957
2024-08-06
Form 10-Q
ID: 0000950170-24-091230
2024-08-06
Form 8-K
ID: 0000950170-24-091227
2024-06-20
Form 8-K
ID: 0000950170-24-075598
2024-05-07
Form 10-Q
ID: 0000950170-24-053981
2024-05-07
Form 8-K
ID: 0000950170-24-053979
2024-04-08
Form 8-K
ID: 0001193125-24-089091
2024-03-12
Form 8-K
ID: 0000950170-24-029672